George Simeon reported conversion involving 198,019 derivative units of ADARx Pharmaceuticals, Inc. at $0.00 for $0 on Sep 28, 2026

Conversion
Form 4 code C. Conversion of a derivative security.
Director
DIR
Filed Sep 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
198,019Series B-1 Preferred Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Indirect · See Note 4
Trade date
Sep 28, 2026Conversion
Filed
Sep 29, 2026, 9:43 PM ET2-day reporting delay
Accession
0001193125-26-408061Code C · Transaction 231482
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 28, 2026Conversion1,304,883$0.00$0Trade 231478
Sep 28, 2026Conversion3,907,547$0.00$0Trade 231477
Sep 28, 2026Conversion1,953,773$0.00$0Trade 231481
Sep 28, 2026Buy592,593$17.00$10,074,081Trade 231471
Sep 28, 2026Buy414,814$17.00$7,051,838Trade 231473
Sep 28, 2026Buy592,593$17.00$10,074,081Trade 231476
Sep 28, 2026Conversion600,962$0.00$0Trade 231479
Sep 28, 2026Conversion1,802,885$0.00$0Trade 231480
Sep 28, 2026Conversion3,334,938——Trade 231468
Sep 28, 2026Conversion1,113,666——Trade 231469
Sep 28, 2026Conversion512,897——Trade 231470
Sep 28, 2026Conversion1,538,691——Trade 231472
Sep 28, 2026Conversion1,667,468——Trade 231474
Sep 28, 2026Conversion169,001——Trade 231475
15 transaction rows in this filing. Joint filers share the same rows.

ADRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ADRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d −13%30d −10%90d180d1y

Footnotes in full

F1: Each share of Series B Preferred Stock, Series B-1 Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted on a 1-for-1.1717 reverse stock split basis into shares of Common Stock upon the closing of the Issuer's initial public offering on September 28, 2026, without payment of further consideration. The Preferred Stock has no expiration date. F2: The Reporting Person is the managing member of SR One Capital Management, LLC ("SR One Capital Management"), which is the sole general partner of SR One Capital Partners I, LP ("SR One Partners I"). SR One Partners I is the sole general partner of SR One Capital Fund I Aggregator, LP ("SR One Fund I Aggregator"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund I Aggregator in which the Reporting Person has no pecuniary interest. F3: The Reporting Person is the managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP ("SR One Opportunities Partners I"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP ("SR One Opportunities Fund I"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest. F4: The Reporting Person is the managing member of SR One Capital Management, which is the managing member of SR One Co-Invest III Manager LLC ("SR One Co-Invest Manager"). SR One Co-Invest Manager is the managing member of SR One Co-Invest III, LLC ("SR One Co-Invest"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Co-Invest in which the Reporting Person has no pecuniary interest. F5: The Reporting Person is the managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP ("SMA Partners"). SMA Partners is the sole general partner of AMZL, LP ("AMZL"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest.